Archimed acquires PET radiopharmaceuticals company IRAB
IRAB, founded in 2016 and headquartered in Barcelona, develops and produces PET radiopharmaceuticals for clinical diagnosis, clinical trials and biomedical research.
Nearly there!
A verification email is on its way to you. Please check your spam or junk folder just in case.
If you do not receive this within five minutes, please try to sign in again. If the problem persists, please email: subscriptions@pei.group .-
Sign in or Register
-
Issues with signing in? Click here
Don't have an account? Register now
-
